OS10.6 Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II studyAndrew B. Lassman, Patrick Roth, Timothy F. Cloughesy et al.|Neuro-Oncology|2019Cited by 11